Innovative approaches of affordable health care in emerging economies

Venkataramanaiah Saddikuti, Mohan Gopalakrishnan, Saji Gopinath

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Demand for affordable care is forcing health-care providers to improve their operational efficiency, cost control, and quality of care. Government agencies are responding by taking necessary measures to curb the cost of pharmaceuticals and medical devices such as the Medical Devices Regulations Act (MDRA) of 2006, the Drugs and Cosmetics (Amendment) Bill 2013, and the formation of the Central Drugs Authority (CDA). Recent revisions to drug price control are helping patients by improving affordability but adding to the cost pressures on pharmaceutical companies. For example, the price of Omez (for 15 tablets) has been reduced to INR 48 (US$0.80) from INR 75 (US$1.2). As a result, the profit margins of wholesalers have been reduced to 7.25% from 10%, whereas retailers’ margins reduced to 13.75% from 20%.1 These steps show progress toward affordable care.

Original languageEnglish (US)
Title of host publicationInnovations in Healthcare Management
Subtitle of host publicationCost-Effective and Sustainable Solutions
PublisherTaylor and Francis
Pages245-260
Number of pages16
ISBN (Electronic)9781482252101
ISBN (Print)9781482252095
DOIs
StatePublished - Jan 1 2015

Fingerprint

Emerging economies
Healthcare
Drugs
Costs
Pharmaceuticals
Medical devices
Price controls
Amendments
Authority
Health care providers
Cost control
Quality of care
Margin
Affordability
Operational efficiency
Retailers
Government agencies
Wholesalers
Profit margin

ASJC Scopus subject areas

  • Economics, Econometrics and Finance(all)
  • Business, Management and Accounting(all)

Cite this

Saddikuti, V., Gopalakrishnan, M., & Gopinath, S. (2015). Innovative approaches of affordable health care in emerging economies. In Innovations in Healthcare Management: Cost-Effective and Sustainable Solutions (pp. 245-260). Taylor and Francis. https://doi.org/10.1201/b18113

Innovative approaches of affordable health care in emerging economies. / Saddikuti, Venkataramanaiah; Gopalakrishnan, Mohan; Gopinath, Saji.

Innovations in Healthcare Management: Cost-Effective and Sustainable Solutions. Taylor and Francis, 2015. p. 245-260.

Research output: Chapter in Book/Report/Conference proceedingChapter

Saddikuti, V, Gopalakrishnan, M & Gopinath, S 2015, Innovative approaches of affordable health care in emerging economies. in Innovations in Healthcare Management: Cost-Effective and Sustainable Solutions. Taylor and Francis, pp. 245-260. https://doi.org/10.1201/b18113
Saddikuti V, Gopalakrishnan M, Gopinath S. Innovative approaches of affordable health care in emerging economies. In Innovations in Healthcare Management: Cost-Effective and Sustainable Solutions. Taylor and Francis. 2015. p. 245-260 https://doi.org/10.1201/b18113
Saddikuti, Venkataramanaiah ; Gopalakrishnan, Mohan ; Gopinath, Saji. / Innovative approaches of affordable health care in emerging economies. Innovations in Healthcare Management: Cost-Effective and Sustainable Solutions. Taylor and Francis, 2015. pp. 245-260
@inbook{08704dff1e2d4924833db28d4b8763c3,
title = "Innovative approaches of affordable health care in emerging economies",
abstract = "Demand for affordable care is forcing health-care providers to improve their operational efficiency, cost control, and quality of care. Government agencies are responding by taking necessary measures to curb the cost of pharmaceuticals and medical devices such as the Medical Devices Regulations Act (MDRA) of 2006, the Drugs and Cosmetics (Amendment) Bill 2013, and the formation of the Central Drugs Authority (CDA). Recent revisions to drug price control are helping patients by improving affordability but adding to the cost pressures on pharmaceutical companies. For example, the price of Omez (for 15 tablets) has been reduced to INR 48 (US$0.80) from INR 75 (US$1.2). As a result, the profit margins of wholesalers have been reduced to 7.25{\%} from 10{\%}, whereas retailers’ margins reduced to 13.75{\%} from 20{\%}.1 These steps show progress toward affordable care.",
author = "Venkataramanaiah Saddikuti and Mohan Gopalakrishnan and Saji Gopinath",
year = "2015",
month = "1",
day = "1",
doi = "10.1201/b18113",
language = "English (US)",
isbn = "9781482252095",
pages = "245--260",
booktitle = "Innovations in Healthcare Management",
publisher = "Taylor and Francis",

}

TY - CHAP

T1 - Innovative approaches of affordable health care in emerging economies

AU - Saddikuti, Venkataramanaiah

AU - Gopalakrishnan, Mohan

AU - Gopinath, Saji

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Demand for affordable care is forcing health-care providers to improve their operational efficiency, cost control, and quality of care. Government agencies are responding by taking necessary measures to curb the cost of pharmaceuticals and medical devices such as the Medical Devices Regulations Act (MDRA) of 2006, the Drugs and Cosmetics (Amendment) Bill 2013, and the formation of the Central Drugs Authority (CDA). Recent revisions to drug price control are helping patients by improving affordability but adding to the cost pressures on pharmaceutical companies. For example, the price of Omez (for 15 tablets) has been reduced to INR 48 (US$0.80) from INR 75 (US$1.2). As a result, the profit margins of wholesalers have been reduced to 7.25% from 10%, whereas retailers’ margins reduced to 13.75% from 20%.1 These steps show progress toward affordable care.

AB - Demand for affordable care is forcing health-care providers to improve their operational efficiency, cost control, and quality of care. Government agencies are responding by taking necessary measures to curb the cost of pharmaceuticals and medical devices such as the Medical Devices Regulations Act (MDRA) of 2006, the Drugs and Cosmetics (Amendment) Bill 2013, and the formation of the Central Drugs Authority (CDA). Recent revisions to drug price control are helping patients by improving affordability but adding to the cost pressures on pharmaceutical companies. For example, the price of Omez (for 15 tablets) has been reduced to INR 48 (US$0.80) from INR 75 (US$1.2). As a result, the profit margins of wholesalers have been reduced to 7.25% from 10%, whereas retailers’ margins reduced to 13.75% from 20%.1 These steps show progress toward affordable care.

UR - http://www.scopus.com/inward/record.url?scp=85061952620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061952620&partnerID=8YFLogxK

U2 - 10.1201/b18113

DO - 10.1201/b18113

M3 - Chapter

AN - SCOPUS:85061952620

SN - 9781482252095

SP - 245

EP - 260

BT - Innovations in Healthcare Management

PB - Taylor and Francis

ER -